Anxiety-related disorders affect a huge segment of our population — 40 million adults (18%) in the United States age 18 and older. In response, Big Pharma has developed numerous drugs to treat anxiety-related disorders, from selective serotonin reuptake inhibitors (SSRIs) like Prozac and Zoloft to tranquilizers (the most popular class being highly addictive benzodiazepines such as Valium and Xanax).
In recent years, CBD has generated a tremendous amount of interest. Not only does evidence suggest CBD counteracts many of THC’s adverse effects, but numerous animal studies and accumulating evidence from human experimental, clinical, and epidemiological studies suggest CBD has powerful anti-anxiety properties. Administered acutely (“as needed”), it appears safe, well-tolerated, and may be beneficial to treat a number of anxiety-related disorders. Similar to SSRIs, CBD may boost signaling through serotonin receptors and may help the hippocampus regenerate neurons.